145 related articles for article (PubMed ID: 19507677)
1. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
[TBL] [Abstract][Full Text] [Related]
2. Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.
Forsberg F; Dicker AP; Thakur ML; Rawool NM; Liu JB; Shi WT; Nazarian LN
Ultrasound Med Biol; 2002 Apr; 28(4):445-51. PubMed ID: 12049957
[TBL] [Abstract][Full Text] [Related]
3. Assessment of angiogenesis: implications for ultrasound imaging.
Forsberg F; Ro RJ; Potoczek M; Liu JB; Merritt CR; James KM; Dicker AP; Nazarian LN
Ultrasonics; 2004 Apr; 42(1-9):325-30. PubMed ID: 15047306
[TBL] [Abstract][Full Text] [Related]
4. Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study.
Forsberg F; Ro RJ; Fox TB; Liu JB; Chiou SY; Potoczek M; Goldberg BB
Ultrasonics; 2011 Apr; 51(3):382-9. PubMed ID: 21144542
[TBL] [Abstract][Full Text] [Related]
5. High and low frequency subharmonic imaging of angiogenesis in a murine breast cancer model.
Dahibawkar M; Forsberg MA; Gupta A; Jaffe S; Dulin K; Eisenbrey JR; Halldorsdottir VG; Forsberg AI; Dave JK; Marshall A; Machado P; Fox TB; Liu JB; Forsberg F
Ultrasonics; 2015 Sep; 62():50-5. PubMed ID: 25979676
[TBL] [Abstract][Full Text] [Related]
6. Comparing Quantitative Immunohistochemical Markers of Angiogenesis to Contrast-Enhanced Subharmonic Imaging.
Gupta A; Forsberg MA; Dulin K; Jaffe S; Dave JK; Halldorsdottir VG; Marshall A; Forsberg AI; Eisenbrey JR; Machado P; Fox TB; Liu JB; Forsberg F
J Ultrasound Med; 2016 Sep; 35(9):1839-47. PubMed ID: 27388814
[TBL] [Abstract][Full Text] [Related]
7. The antivascular action of physiotherapy ultrasound on murine tumors.
Wood AK; Ansaloni S; Ziemer LS; Lee WM; Feldman MD; Sehgal CM
Ultrasound Med Biol; 2005 Oct; 31(10):1403-10. PubMed ID: 16223644
[TBL] [Abstract][Full Text] [Related]
8. Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models.
Eisenbrey JR; Wilson CC; Ro RJ; Fox TB; Liu JB; Chiou SY; Forsberg F
Ultrasonics; 2013 Sep; 53(7):1384-91. PubMed ID: 23659876
[TBL] [Abstract][Full Text] [Related]
9. The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Marshall A; Liu JB; Chiou SY; Merton DA; Machado P; Dicker AP; Nazarian LN
Mol Imaging; 2014; 13():1-9. PubMed ID: 24622811
[TBL] [Abstract][Full Text] [Related]
10. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm.
Bunte RM; Ansaloni S; Sehgal CM; Lee WM; Wood AK
Ultrasound Med Biol; 2006 Mar; 32(3):453-61. PubMed ID: 16530105
[TBL] [Abstract][Full Text] [Related]
11. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma model.
Seiler GS; Ziemer LS; Schultz S; Lee WM; Sehgal CM
Cancer Imaging; 2007 Dec; 7(1):216-23. PubMed ID: 18083651
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.
Lamuraglia M; Barrois G; Le Guillou-Buffello D; Santin M; Kerbol A; Comperat E; Coron A; Lucidarme O; Bridal SL
Technol Cancer Res Treat; 2020; 19():1533033819886896. PubMed ID: 32065066
[TBL] [Abstract][Full Text] [Related]
14. Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading.
Schroeder RJ; Hauff P; Bartels T; Vogel K; Jeschke J; Hidajat N; Maeurer J
Ultrasound Med Biol; 2001 Jun; 27(6):761-71. PubMed ID: 11516536
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis model for ultrasound contrast research: exploratory study.
Lucidarme O; Nguyen T; Kono Y; Corbeil J; Choi SH; Varner J; Mattrey RF
Acad Radiol; 2004 Jan; 11(1):4-12. PubMed ID: 14746396
[TBL] [Abstract][Full Text] [Related]
16. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
17. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model.
Pollard RE; Sadlowski AR; Bloch SH; Murray L; Wisner ER; Griffey S; Ferrara KW
Technol Cancer Res Treat; 2002 Dec; 1(6):459-70. PubMed ID: 12625773
[TBL] [Abstract][Full Text] [Related]
18. [Value of ultrasound-targeted vascular endothelial growth factor receptor-2 in non-invasive monitoring of anti-angiogenic response in nude mice with subcutaneous xenograft model].
Wang L; Lu YH; Wang TY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):856-860. PubMed ID: 33113627
[No Abstract] [Full Text] [Related]
19. Contrast-enhanced ultrasound with perflubutane in the assessment of anti-angiogenic effects: early prediction of the anticancer activity of bevacizumab in a mouse xenografted model.
Watanabe R; Munemasa T; Matsumura M
Ultrasound Med Biol; 2015 Sep; 41(9):2497-505. PubMed ID: 26022792
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
